Aptose Biosciences (Aptose Biosciences) Institutional Ownership : 0.02% (As of May. 05, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Aptose Biosciences Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aptose Biosciences's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aptose Biosciences's Insider Ownership is 11.06%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aptose Biosciences's Float Percentage Of Total Shares Outstanding is 80.94%.

Aptose Biosciences Institutional Ownership Historical Data

The historical data trend for Aptose Biosciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Institutional Ownership Chart

Aptose Biosciences Historical Data

The historical data trend for Aptose Biosciences can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	0.06	0.06	0.05	0.05	0.05	0.05	0.02	0.02	0.02	0.02

Aptose Biosciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Aptose Biosciences (Aptose Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (NAS:APTO) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

LTI:Germany APS:Canada

Address

251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3

Website

https://www.aptose.com

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Executives

Bernd R. Seizinger	director	535 BOYLSTON STREET, BOSTON MA 02116
William G. Rice	director, officer: Chair, President & CEO	C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Fletcher Payne	officer: SR VP & Chief Fin. Officer	260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO CA 94080
Philippe Ledru	officer: Chief Commercial Officer	C/O APTOSE BIOSCIENCES INC., 2511 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Denis R Burger	director	CYTODYN INC., 1111 MAIN STREET, SUITE 660, VANCOUVER WA 98660
Erich Platzer	director
Rafael Bejar	officer: Chief Medical Officer	C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Wilson Donald R. Jr.	10 percent owner	540 W. MADISON ST., SUITE 2500, CHICAGO IL 60661
Drw Holdings, Llc	10 percent owner	540 W. MADISON ST., SUITE 2500, CHICAGO IL 60661
Drw Commodities, Llc	10 percent owner	540 W. MADISON ST., SUITE 2500, CHICAGO IL 60661
Warren Whitehead	director	C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Gregory K. Chow	officer: Senior VP & CFO	C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Jotin Marango	officer: Senior VP, Chief Bus. Officer	C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3
Caroline M Loewy	director	300 ELLIOTT AVE WEST, SUITE 500, SEATTLE WA 98119-4114
Mark D. Vincent	director	C/O APTOSE BIOSCIENCES INC., 251 CONSUMERS ROAD, SUITE 1105, TORONTO A6 M2J 4R3